Determinants of Ocular Surface Biogeography
Determinants of Ocular Surface Biogeography
批准号:
10396467
负责人:
Michael S Gilmore
金额:
$41.23万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31
关键词:
AnatomyAntibiotic ResistanceAutomobile DrivingBiological MarkersBlindnessBotanyCaringChemicalsCommunicable DiseasesCorneaDataDevelopmentEpithelialEyeEye InfectionsGenomicsHumanImmunologicsIn VitroInfectionInfectious Skin DiseasesIntegration Host FactorsIntuitionKnowledgeLifeMicrobeModelingMolecularMucous MembraneMulti-Drug ResistanceMusPathogenicityPositioning AttributePropertyResearchResolutionSiteSkin TissueSoft Tissue InfectionsSurfaceTimeTissuesZoologyantimicrobialconjunctivainsightkeratinizationlensmethicillin resistant Staphylococcus aureusmicrobialocular surfaceresidencesenescencesoft tissuetargeted treatmenttransposon sequencing
中文摘要
眼睛湿润的上皮表面在化学上、免疫学上是独特的,因此,在生态上是独特的
与周围附件的角质化表面有很大的不同。尽管直觉上很明显
这将对栖息并感染眼睛上这些不同部位的微生物产生重大影响
我们在初步数据中表明,这对甲氧西林耐药类型有深远的影响
感染湿性和角化性眼上皮组织的金黄色葡萄球菌(MRSA)。生物地理学的研究有
在动物学和植物学中已经建立了很长时间,然而直到基因组学给了我们高分辨率
观察不同解剖部位微生物之间的差异的能力,是否有可能研究
人体解剖的生物地理学,包括眼睛和周围组织-及其对传染性疾病的影响
疾病。我们使用这种新的生物地理透镜来观察眼表景观,并在初步数据中
首次表明,在所有解剖部位,耐多药眼部感染的主要原因之一,
MRSA,专门感染眼部潮湿的上皮表面,而不是附件的角化上皮。
在理解为什么一种MRSA谱系CC5/USA100更适合感染
角膜和结膜。由于眼表感染是全球视力丧失的主要原因,
CC5/USA100 MRSA代表了对抗生素耐药性最高的MRSA分支,迫切需要
了解眼部耐甲氧西林金黄色葡萄球菌生物地理的驱动因素。实现我们的目标将确定准确的东道主
选择一种MRSA谱系而不是另一种谱系的条件,将确定宿主因素
有助于这次选择,并将确定使CC5菌株具有不同能力的微生物因素
持续停留在湿润的眼表上皮细胞,作为感染的先兆。这件事的重要性
信息是,它将提供新的和关键的见解,使眼睛护理专业人员能够管理
通过发现生物标志物和关键眼部,减少感染的可能性
地面防御系统。此外,它将确定致病MRSA谱系的关键特征,现在可以作为靶点
从治疗上讲。填补这一关键的知识缺口将是推动该领域向前发展的重大进步
减轻全球视力丧失的一个重要原因。
英文摘要
The wet epithelial surface of the eye is chemically, immunologically and as a result, ecologically unique and
profoundly different from the keratinized surfaces of the surrounding adnexa. Although it is intuitively obvious
that this would have a substantial impact on the microbes that inhabit and infect these distinct sites on the ocular
landscape, we show in preliminary data that this has profound consequences for the types of methicillin resistant
S. aureus (MRSA) that infect wet versus keratinized ocular epithelial tissues. The study of biogeography has
been long established in zoology and botany, however only since genomics has given us the high‐resolution
power to view distinctions between microbes at various anatomical sites, has it been possible to study the
biogeography of the human anatomy, including the eye and surrounding tissues – and its impact on infectious
diseases. We used this new biogeographical lens to view the ocular surface landscape, and in preliminary data
showed for the first time, that a leading cause of multidrug resistant ocular infections at all anatomical sites,
MRSA, specializes in infecting the ocular wet epithelial surface versus the keratinized epithelium of the adnexa.
There is a critical gap in understanding why one MRSA lineage, CC5/USA100, is better positioned to infect the
cornea and conjunctiva. As ocular surface infections are leading causes of vision loss worldwide, and
CC5/USA100 MRSA represent the most highly antibiotic resistant MRSA clade, there is an urgency to
understanding the drivers of MRSA biogeography for the eye. Achieving our aims will identify the precise host
conditions under which selection for one MRSA lineage over another occurs, will identify the host factors
contributing to this selection, and will identify the microbial factors that differentially empower CC5 strains to
persist on the wet epithelium of the ocular surface as a forerunner to infection. The importance of this
information is that it will provide new and critical insights that will allow eye care professionals to manage the
ocular surface in a way that will reduce the likelihood of infection, by discovering biomarkers and key ocular
surface defenses. Further, it will identify critical features of pathogenic MRSA lineages that now can be targeted
therapeutically. Filling this critical knowledge gap will be a major advance for driving the field forward to
mitigate an important global cause of vision loss.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
-
批准号:10569041
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2022
-
负责人:Michael S Gilmore
-
依托单位:
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
-
批准号:10464409
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2022
-
负责人:Michael S Gilmore
-
依托单位:
Determinants of Ocular Surface Biogeography
-
批准号:10596574
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:Michael S Gilmore
-
依托单位:
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
-
批准号:9926227
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2019
-
负责人:Michael S Gilmore
-
依托单位:
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
-
批准号:9810471
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2019
-
负责人:Michael S Gilmore
-
依托单位:
Administrative Core
-
批准号:9151285
-
项目类别:
-
资助金额:$15.71万
-
财政年份:2016
-
负责人:Michael S Gilmore
-
依托单位:
Subproject 3 New Approaches to Treatment and Prevention of Antibiotic Resistant Infection
-
批准号:9151288
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2016
-
负责人:Michael S Gilmore
-
依托单位:
Molecular Basis for Ocular Surface Tropism in Conjunctivitis
-
批准号:9264533
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2014
-
负责人:Michael S Gilmore
-
依托单位:
Molecular Basis for Ocular Surface Tropism in Conjunctivitis
-
批准号:8670576
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2014
-
负责人:Michael S Gilmore
-
依托单位:
Identification of infection-critical S. aureus traits by TnSeq
-
批准号:8660637
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Enterococcal Pathogenesis:Role of Cytolysin
-
批准号:9322594
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Enterococcal Pathogenesis:Role of Cytolysin
-
批准号:8611481
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Enterococcal Pathogenesis:Role of Cytolysin
-
批准号:9117371
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Identification of infection-critical S. aureus traits by TnSeq
-
批准号:8564610
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Modeling CRISPR to Preserve Antibiotics
-
批准号:8642660
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Modeling CRISPR to Preserve Antibiotics
-
批准号:8503236
-
项目类别:
-
资助金额:$22.01万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Targeting and Containing the Spread of VRSA
-
批准号:8376874
-
项目类别:
-
资助金额:$29.15万
-
财政年份:2012
-
负责人:Michael S Gilmore
-
依托单位:
Adminstrative Core
-
批准号:8376878
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2012
-
负责人:Michael S Gilmore
-
依托单位:
2011 Microbial Adhesion & Signal Transduction Gordon Research Conference
-
批准号:8118646
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2011
-
负责人:Michael S Gilmore
-
依托单位:
Targeting and Containing the Spread of VRSA
-
批准号:8202949
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2011
-
负责人:Michael S Gilmore
-
依托单位:
海外基金